Stocktoria

BGM Group Ltd. BGM

Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-01-12
Chart by TradingView
5/9
Piotroski F — financial health
7.83
Altman Z″ — distress risk · safe
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2024FY2023FY2022FY2021FY2020
Financials
Revenue$25.1M$46.5M$64.9M$57.1M$50.0M
Gross profit$4.1M$1.8M$6.2M$5.6M$7.5M
Operating income-$563,771-$2.6M$2.1M$2.4M$4.8M
Net income-$1.4M-$7.8M$1.1M$3.2M$5.1M
Operating cash flow$544,238$312,209$12.7M$345,034$5.1M
Free cash flow$304,105$132,450$10.6M-$1.1M$4.6M
Total assets$53.0M$51.3M$64.5M$75.4M$48.1M
Total liabilities$8.9M$6.9M$9.6M$18.7M$19.3M
Shareholders' equity$42.7M$44.4M$55.0M$56.7M$28.8M
Ratios
Gross margin16.4%3.8%9.6%9.9%15.1%
Operating margin-2.2%-5.6%3.2%4.2%9.6%
Net margin-5.7%-16.7%1.7%5.5%10.1%
FCF margin1.2%0.3%16.4%-2.0%9.2%
Return on assets-2.7%-15.2%1.7%4.2%10.5%
Return on equity-3.4%-17.5%2.0%5.6%17.6%
Current ratio3.395.183.272.222.04
Revenue growth-46.0%-28.3%13.6%14.1%

Why these scores methodology →

Piotroski F-score: 5/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: 7.83 (safe)

  • Working capital / assets 0.396
  • Retained earnings / assets 0.082
  • EBIT / assets -0.011
  • Equity / liabilities 4.797

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001779578 · as of 2024-09-30. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.